Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Luana, Calabrò"'
Autor:
Luana Calabrò, Giuseppe Bronte, Federica Grosso, Luigi Cerbone, Angelo Delmonte, Fabio Nicolini, Massimiliano Mazza, Anna Maria Di Giacomo, Alessia Covre, Maria Fortunata Lofiego, Lucio Crinò, Michele Maio
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Pleural mesothelioma (PM) is an aggressive and rare disease, characterized by a very poor prognosis. For almost two decades, the world standard treatment regimen for unresectable PM has consisted of a platinum-based drug plus pemetrexed, leading to a
Externí odkaz:
https://doaj.org/article/8927fd98d7b248cbac772e012b06e713
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Externí odkaz:
https://doaj.org/article/2d089392ca0e43ac9eda67cf4918da8e
Autor:
Laura Mercatali, Silvia Vanni, Giacomo Miserocchi, Chiara Liverani, Chiara Spadazzi, Claudia Cocchi, Chiara Calabrese, Lorena Gurrieri, Valentina Fausti, Nada Riva, Damiano Genovese, Enrico Lucarelli, Maria Letizia Focarete, Toni Ibrahim, Luana Calabrò, Alessandro De Vita
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
In the field of nanomedicine a multitude of nanovectors have been developed for cancer application. In this regard, a less exploited target is represented by connective tissue. Sarcoma lesions encompass a wide range of rare entities of mesenchymal or
Externí odkaz:
https://doaj.org/article/f885ba5b521043b3ab3517835c5c98b4
Autor:
Michele Maio, Michael Lahn, Anna Maria Di Giacomo, Alessia Covre, Luana Calabrò, Ramy Ibrahim, Bernard Fox, The Siena Think Tank
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-12 (2021)
Abstract Background The yearly Think Tank Meeting of the Italian Network for Tumor Biotherapy (NIBIT) Foundation, brings together in Siena, Tuscany (Italy), experts in immuno-oncology to review the learnings from current immunotherapy treatments, and
Externí odkaz:
https://doaj.org/article/a9b82c832f1c477f829ff00e1f9882ca
Autor:
Lucia Brilli, Luana Calabrò, Michele Campanile, Tania Pilli, Cristina Agostinis, Alfonso Cerase, Michele Maio, Maria Grazia Castagna
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 64, Iss 4, Pp 483-486 (2020)
SUMMARY Checkpoint inhibitors have substantially improved the prognosis for patients with advanced malignancy. Treatment with immunomodulants has the ability to reactivate the immune system against tumor cells, but can also trigger the development of
Externí odkaz:
https://doaj.org/article/4c5fe0fb2ce94489ba3bb9d87c10c843
Autor:
Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre, Michele Maio
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-10 (2019)
Abstract Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoclonal antibodies to immune check
Externí odkaz:
https://doaj.org/article/db9302128def4972b7b8e1ebf814732e
Autor:
Elena Pancisi, Anna Maria Granato, Emanuela Scarpi, Laura Ridolfi, Silvia Carloni, Cinzia Moretti, Massimo Guidoboni, Francesco De Rosa, Sara Pignatta, Claudia Piccinini, Valentina Soldati, Luana Calabrò, Massimo Framarini, Monica Stefanelli, Jenny Bulgarelli, Marcella Tazzari, Francesca Fanini, Massimiliano Petrini
Publikováno v:
Vaccines, Vol 10, Iss 7, p 999 (2022)
Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Sever
Externí odkaz:
https://doaj.org/article/81747b5ebaba429caba0e93b295c5085
Autor:
Maria Fortunata Lofiego, Sara Cannito, Carolina Fazio, Francesca Piazzini, Ornella Cutaia, Laura Solmonese, Francesco Marzani, Carla Chiarucci, Anna Maria Di Giacomo, Luana Calabrò, Sandra Coral, Michele Maio, Alessia Covre, on behalf of the EPigenetic Immune-Oncology Consortium Airc (EPICA) Investigators
Publikováno v:
Epigenomes, Vol 5, Iss 4, p 27 (2021)
Malignant pleural mesothelioma (MPM) is an aggressive malignancy with a severe prognosis, and with a long-standing need for more effective therapeutic approaches. However, treatment with immune checkpoint inhibitors is becoming an increasingly effect
Externí odkaz:
https://doaj.org/article/4873e483dc294f2192f580253fb9978d
Autor:
Anna M. Di Giacomo, Gianluca Giacobini, Gabriele Anichini, Claudia Gandolfo, Vincenzo D'alonzo, Luana Calabrò, Maria F. Lofiego, Maria G. Cusi, Michele Maio
Publikováno v:
European Journal of Cancer. 171:143-149
The protective role against SARS-CoV-2 infection by the third booster dose of mRNA vaccines in cancer patients with solid malignancies is presently unknown. We prospectively investigated the occurrence of COVID-19 in cancer patients on active therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d40c7ecc67a1074b0a0c8c7a7e5bf5
https://doi.org/10.1016/j.ejca.2022.05.018
https://doi.org/10.1016/j.ejca.2022.05.018
Autor:
Michele Maio, Mario Mandalà, Diana Giannarelli, Monica Valente, Luana Calabrò, Roberto Camerini, Alessia Covre, Giovanni Amato, Ornella Cutaia, Paolo Marchetti, Massimo Guidoboni, Pietro Quaglino, Michele Guida, Pier Francesco Ferrucci, Michele Del Vecchio, Vanna Chiarion-Sileni, Anna Maria Di Giacomo
Purpose:Phase II trials have shown encouraging activity with ipilimumab plus fotemustine and ipilimumab plus nivolumab in melanoma brain metastases. We report the primary analysis and 4-year follow-up of the NIBIT-M2 study, the first phase III trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3352d0e0f6aadeb6a82a401e9a8a1c74
https://doi.org/10.1158/1078-0432.c.6530379.v1
https://doi.org/10.1158/1078-0432.c.6530379.v1
